Anthony Wong, MD, PhD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentRadiation Oncology
Address1600 Divisadero Street
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wong A, Chmura SJ. PMRT: Please Mind Randomized Trials. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):976-977. PMID: 28721908.
      View in: PubMed
    2. Das LC, Golden DW, Perevalova E, Wong A, De Nardo K, Stepaniak C, Joyce DS, McCabe BP, Hasan Y, Chmura SJ, McCall A. A feasibility study of 2-mm bolus for postmastectomy radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):161-166. PMID: 28089526.
      View in: PubMed
    3. Wong A, Watson SP, Pitroda SP, Son CH, Das LC, Stack ME, Uppal A, Oshima G, Khodarev NN, Salama JK, Weichselbaum RR, Chmura SJ. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT). Cancer. 2016 07 15; 122(14):2242-50. PMID: 27206146.
      View in: PubMed
    4. Ranoa DR, Parekh AD, Pitroda SP, Huang X, Darga T, Wong A, Huang L, Andrade J, Staley JP, Satoh T, Akira S, Weichselbaum RR, Khodarev NN. Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs. Oncotarget. 2016 May 03; 7(18):26496-515. PMID: 27034163.
      View in: PubMed
    5. Wong A, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO, Goodman KA, Keating NL. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract. 2014 Sep; 10(5):e360-7. PMID: 24986112; PMCID: PMC4161733.
    6. Meftah M, Yadav A, Wong A, Ranawat AS, Ranawat CS. A novel method for accurate and reproducible functional cup positioning in total hip arthroplasty. J Arthroplasty. 2013 Aug; 28(7):1200-5. PMID: 23462497.
      View in: PubMed
    7. Zhang CC, Pavlicek A, Zhang Q, Lira ME, Painter CL, Yan Z, Zheng X, Lee NV, Ozeck M, Qiu M, Zong Q, Lappin PB, Wong A, Rejto PA, Smeal T, Christensen JG. Biomarker and pharmacologic evaluation of the ?-secretase inhibitor PF-03084014 in breast cancer models. Clin Cancer Res. 2012 Sep 15; 18(18):5008-19. PMID: 22806875.
      View in: PubMed
    8. Meftah M, Wong A, Nawabi DH, Yun RJ, Ranawat AS, Ranawat CS. Pain management after total knee arthroplasty using a multimodal approach. Orthopedics. 2012 May; 35(5):e660-4. PMID: 22588407.
      View in: PubMed
    9. Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong A, Liu T, Keuhne AI, Li S, Woods VL, Chandran K, Dye JM, Saphire EO. Structural basis for differential neutralization of ebolaviruses. Viruses. 2012 04; 4(4):447-70. PMID: 22590681; PMCID: PMC3347318.
    10. Dias JM, Kuehne AI, Abelson DM, Bale S, Wong A, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol. 2011 Nov 20; 18(12):1424-7. PMID: 22101933; PMCID: PMC3230659.
    11. Carette JE, Raaben M, Wong A, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011 Aug 24; 477(7364):340-3. PMID: 21866103; PMCID: PMC3175325.
    12. Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, Qiu M, Painter CL, Wong A, Kraynov E, Arango ME, Mehta PP, Popoff I, Casperson GF, Los G, Bender S, Anderes K, Christensen JG, VanArsdale T. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin Cancer Res. 2010 Nov 01; 16(21):5177-88. PMID: 20829331.
      View in: PubMed
    13. Wong A, Sandesara RG, Mulherkar N, Whelan SP, Chandran K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol. 2010 Jan; 84(1):163-75. PMID: 19846533; PMCID: PMC2798398.
    14. Zhang C, Yan Z, Painter CL, Zhang Q, Chen E, Arango ME, Kuszpit K, Zasadny K, Hallin M, Hallin J, Wong A, Buckman D, Sun G, Qiu M, Anderes K, Christensen JG. PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts. Clin Cancer Res. 2009 Jul 15; 15(14):4630-40. PMID: 19584159.
      View in: PubMed
    15. Borah S, Wong A, Steitz JA. Drosophila hnRNP A1 homologs Hrp36/Hrp38 enhance U2-type versus U12-type splicing to regulate alternative splicing of the prospero twintron. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2577-82. PMID: 19196985; PMCID: PMC2636732.
    16. Scamborova P, Wong A, Steitz JA. An intronic enhancer regulates splicing of the twintron of Drosophila melanogaster prospero pre-mRNA by two different spliceosomes. Mol Cell Biol. 2004 Mar; 24(5):1855-69. PMID: 14966268; PMCID: PMC350559.
    Anthony's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.